Malaysia 3D Imaging Market Analysis Report 2022 to 2030

Malaysia 3D Imaging Market Analysis

$ 3999

Malaysia's 3D imaging market is projected to grow from $0.05 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. The market will be driven by increasing healthcare expenditure, rising demand for advanced diagnostic tools, and growing awareness about the benefits of 3D Imaging. The market is segmented by product, application, end-user & portability. Some of the major players include GE Healthcare, Siemens Healthineers & Philips Healthcare.

ID: IN10MYDH001 CATEGORY: Digital Health GEOGRAPHY: Malaysia AUTHOR: Vidhi Upadhyay

Buy Now

Malaysia 3D Imaging Market Executive Summary

Malaysia's 3D imaging market is projected to grow from $0.05 Bn in 2022 to $xx Bn by 2030, registering a CAGR of xx% during the forecast period of 2022-30. According to the World Health Organization Global Health Expenditure database, Malaysia's overall healthcare expenditure (%GDP) increased from 3.75 per cent in 2018 to 3.8 per cent in 2019. Health spending on early illness detection programmes grew 39.7% from 2019 to 2020. According to The Global Cancer Observatory 2020, out of a total population of 32.36 Mn, the number of new cases of cancer was 0.48 Mn with 0.29 Mn deaths. According to the Malaysian Department of Statistics, ischemic heart disease remained the top cause of death in 2020, accounting for 17.0% of the 109,155 medically certified fatalities (Statistics, 2021).

The Malaysia some of the commonly used 3D Imaging modalities include computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. In Malaysia, 3D Imaging is used in a variety of fields, including cardiology, orthopaedics, neurology, and cancer. 3D Imaging is used in cardiology to see the heart in three dimensions, assisting in the diagnosis and treatment of various cardiac problems. 3D Imaging is utilised in orthopaedics to design tailored surgery plans and implants, which improves patient outcomes. 3D Imaging is used in neurology to view the brain and nervous system, assisting in the diagnosis and treatment of neurological illnesses. 3D Imaging is used in oncology to discover and monitor malignancies as well as schedule radiation therapy.

In February 2022, ALTY Orthopaedic Hospital, a healthcare provider specialised in surgical and non-surgical therapies as well as dedicated care for orthopaedic and musculoskeletal diseases, announced the acquisition of Malaysia's first EOS imaging equipment which is an advanced 3D Imaging system which emits 50% to 85% less radiation than standard X-ray systems and up to 95%³ less dosage than basic computed tomography (CT) scans; In accordance with the ALARA (As Low As Reasonably Achievable) concept.

malaysia 3D imaging market analysis

Market Dynamics

Market Growth Drivers

In January 2023, Abdul Latif Jameel Health, made a distribution agreement with iSono Health, to launch a portable breast imaging scanner called “ATUSA scanner” across 31 countries including Malaysia. Such advancements along with several other factors are driving the Malaysian 3D Imaging market, including rising healthcare spending, increased need for better diagnostic tools, and expanding awareness of the benefits of 3D imaging. The Malaysian government has made significant investments in healthcare infrastructure, including the construction of new hospitals and clinics, fuelling demand for imaging equipment. Furthermore, the ageing population and the rising frequency of chronic illnesses are driving market expansion. 3D Imaging has various advantages over standard 2D imaging, such as enhanced accuracy and visualisation, which is boosting demand for these sophisticated diagnostic technologies in Malaysia. Finally, the increasing number of healthcare providers and market competitiveness are likely to boost expansion in Malaysia's 3D Imaging market.

Market Restraints

While the Malaysian 3D Imaging market is predicted to increase, there are some challenges that may limit its expansion. The expensive cost of 3D Imaging technology is one key impediment, which may limit its adoption, particularly among smaller healthcare facilities. Furthermore, a scarcity of experienced healthcare workers capable of operating and interpreting 3D medical pictures may limit its acceptance and usage. Concerns have also been raised about the safety of some imaging modalities, such as CT scans, which can expose patients to dangerous quantities of radiation. Another impediment is the absence of defined procedures and recommendations for the use of 3D Imaging in clinical practice, which can result in variations in diagnosis and treatment.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Globetronics (MYS)
Fusionex International (MYS)

Notable Deals

In July 2022, GE Healthcare created a new and enhanced e-commerce platform to provide better access to excellent healthcare in Asia Pacific countries
The year 2022 onwards, Siemens Healthineers Academy Malaysia began providing medical imaging education and training to the imaging professional

Healthcare Policies and Regulatory Landscape

In Malaysia, the Ministry of Health (MOH) is the primary regulatory entity in charge of medical device approval and regulation, including 3D Imaging equipment. The MOH has developed recommendations for the safe and effective use of medical devices, including imaging equipment in clinical practice. The Malaysian Medical Device Authority (MDA) is responsible for implementing medical device rules and registering medical devices. The Malaysian Investment Development Authority (MIDA) announced a programme to encourage the development of medical device businesses, particularly 3D imaging, by offering incentives and support to both domestic and foreign investors.

Reimbursement Scenario

The Ministry of Health in Malaysia is in charge of reimbursement for diagnostic imaging (MOH). The Malaysian Ministry of Health (MOH) reimburses medical services through many schemes, including the National Health Financing Scheme (Skim Kesihatan Malaysia or SKM) and the Social Security Organization (SOCSO). In terms of reimbursement, the Malaysian government covers specific medical treatments, including those requiring the use of 3D Imaging technology. The reimbursement rates, however, differ based on the operation and the type of imaging equipment utilised. Medical operations involving the use of 3D Imaging technology are also covered by private insurance companies in Malaysia, however, coverage and reimbursement rates vary depending on the insurance policy and provider.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Malaysia 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.